超声造影应用于乳腺癌的新进展  

New advances in the use of contrast-enhanced ultrasound in breast cancer

作　　者：古常燕 聂芳[1] GU Changyan;NIE Fang(Ultrasound Medical Center,Gansu Province Clinical Research Center for Ultrasonography,Gansu Province Medical Engineering Research Center for Intelligence Ultrasound,The Second Hospital of Lanzhou University,Lanzhou 730030,China)

机构地区：[1]兰州大学第二医院超声医学中心,甘肃省超声影像临床医学研究中心,甘肃省智能超声医学工程研究中心,甘肃兰州730030

出　　处：《兰州大学学报(医学版)》2025年第3期90-94,共5页Journal of Lanzhou University(Medical Sciences)

基　　金：甘肃省科技重大专项计划资助项目(23ZDFA006);兰州大学第二医院“萃英科技创新”计划资助项目(CY2023-YB-B02)。

摘　　要：乳腺癌已成为全球女性最常见的癌症,严重影响女性健康,给世界公共卫生带来巨大挑战。早期诊断乳腺癌并于术前确定其组织学分级和分子亚型可指导手术方案以及预后,提高患者生存率,获得良好预后。超声造影已广泛应用于乳腺癌,本文就超声造影在乳腺癌的诊断、术前预测组织学分级、分子亚型以及新辅助化疗疗效等方面的应用作一综述。Breast cancer has become the most common cancer among women globally,seriously affecting women's health and posing a great challenge to world public health.Early diagnosis of breast cancer and preoperative determination of its histological grade and molecular subtype can guide the surgical plan and prognosis,and improve the survival rate of patients and obtain a good prognosis.Contrast-enhanced ultra-sound has been widely used in breast cancer,and this article reviewed the use of contrast-enhanced ultrasound in the diagnosis of breast cancer,preoperative prediction of histological grading,molecular subtypes,and the efficacy of neoadjuvant chemotherapy.

关 键 词：乳腺癌 超声造影 诊断 组织学分级 分子亚型 新辅助化疗 

分 类 号：R445.1[医药卫生—影像医学与核医学]